CCM Meeting Heart Failure Symposium for Primary Care and Internal Medicine Physicians 2021

Description

+ Include: 30 videos + 1 pdf, size: 3.23 GB

+ Target Audience: primary care physicians, internal medicine physician and trainees

+ Sample video: contact me for sample video

+ Topics:

SDHF PCIMP Brochure.pdf
SESSION I – Risk Factors and Prevention – Approaches to Treating Diabetes that Reduce CV Events.mp4
SESSION I – Risk Factors and Prevention – Biomarkers for Detecting Risk of HF.mp4
SESSION I – Risk Factors and Prevention – HF Treatment How Do We Interpret BNP and NT-proBNP Levels in Obese Patients.mp4
SESSION I – Risk Factors and Prevention – Managing Patients’ Hypertension During the COVID-19 Era.mp4
SESSION I – Risk Factors and Prevention – Novelties in Lipid Lowering Therapies Can Statin Therapy Reduce Residual Risk.mp4
SESSION II – Cardiac Hypertrophy, Amyloid and Other Infiltrative Diseases – Advances in the Diagnosis and Management of Amyloid Disease.mp4
SESSION II – Cardiac Hypertrophy, Amyloid and Other Infiltrative Diseases – Diagnosing and Treating 73 y o Patient.mp4
SESSION II – Cardiac Hypertrophy, Amyloid and Other Infiltrative Diseases – Recognizing and Treating HFpEF.mp4
SESSION III – Focus on COVID-19 and Disparities in Care – Cardiovascular Manifestations of COVID-19.mp4
SESSION III – Focus on COVID-19 and Disparities in Care – COVID-19 Should You Use Steroids for Patients.mp4
SESSION III – Focus on COVID-19 and Disparities in Care – Recognizing and Mitigating Disparities in Care During the Pandemic.mp4
SESSION III – Focus on COVID-19 and Disparities in Care – Role of the Renin Angiotensin System in COVID-19 Infections.mp4
SESSION III – Focus on COVID-19 and Disparities in Care – Treatment of COVID-19 Which Drugs Were Debunked.mp4
SESSION IV – Advances in Heart Failure Management – Evolution of Heart Failure Treatment.mp4
SESSION IV – Advances in Heart Failure Management – Heart Failure Treatment How to Decide Which Therapy.mp4
SESSION IV – Advances in Heart Failure Management – Learning from CHAMP-HF How Can We Improve Drug Therapy.mp4
SESSION IV – Advances in Heart Failure Management – Management of Sleep Disordered Breathing in Heart Failure.mp4
SESSION IV – Advances in Heart Failure Management – New Pharmacological Therapy Guidelines for HFrEF in 2021.mp4
SESSION IV – Advances in Heart Failure Management – The PARADIGM-HF Trial Why Is Sacubitril Valsartan.mp4
SESSION IV – Advances in Heart Failure Management – The PARAGON Trial How Can SacubitrilValsartan.mp4
SESSION IV – Advances in Heart Failure Management – The PIONEER-HF Trial What Are The Long Term Benefits.mp4
SESSION V – Biomarkers and Devices to Detect and Treat Heart Failure – ACC AHA HFSA Guidelines for the Use of Natriuretic Peptides.mp4
SESSION V – Biomarkers and Devices to Detect and Treat Heart Failure – Devices for Detecting Worsening Heart Failure.mp4
SESSION V – Biomarkers and Devices to Detect and Treat Heart Failure – Devices for Preventing Stroke in Patients.mp4
SESSION V – Biomarkers and Devices to Detect and Treat Heart Failure – Heart Failure Prevention and Treatment.mp4
SESSION V – Biomarkers and Devices to Detect and Treat Heart Failure – Novelties in Pacemakers and Defibrillators.mp4
SESSION VI – Recognizing and Treating Advanced Heart Failure – Advances in Temporary Mechanical Support for Acute Heart Failure.mp4
SESSION VI – Recognizing and Treating Advanced Heart Failure – Detecting and Treating Pulmonary Arterial Hypertension.mp4
SESSION VI – Recognizing and Treating Advanced Heart Failure – From Pulsatile-Flow to Continuous-Flow Left Ventricular Assist Devices.mp4
SESSION VI – Recognizing and Treating Advanced Heart Failure – Stage D Heart Failure How to Use Biomarkers, Cardio Pulmonary.mp4